Journals / Neurological sciences and neurophysiology (Online) / 2018 / Cilt: 35 - Sayı: 2

The psychiatric profiles of patients with temporal lobe epilepsy associated with neuronal auto-antibodies

Pages
84–90
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was important to note that depression and psychosis are more frequent in patients with NAA, whereas seronega- tive patients displayed social phobia more frequently.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Neuronal auto-antibodies (NAA) have recently been shown in some patients with chronic temporal lobe epilepsy (TLE).
📊
Key Findings & Data:Psychiatric comorbidity is a significant part of the TLE course and a different profile can be a marker for “autoimmune” epilepsy.
💡
Conclusion & Impact:It was important to note that depression and psychosis are more frequent in patients with NAA, whereas seronega- tive patients displayed social phobia more frequently.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Neuronal auto-antibodies (NAA) have recently been shown in some patients with chronic temporal lobe epilepsy (TLE). Psychiatric comorbidity is a significant part of the TLE course and a different profile can be a marker for “autoimmune” epilepsy. For this reason, we aimed to determine the psychiatric profiles of TLE patients associated with NAA and their differen- tiating features. Methods: The sera of the included TLE patients have been tested for 8 neuronal auto-antibodies. The standardized, detailed psychiatric interviews and questionnaires (International Neuropsychiatric Interview; M.I.N.I. Turkish edition, Yale – Brown Ob- sessive Compulsive scale (YBOCS), The Scale for the Assessment of Positive Symptoms (SAPS)) were performed by the same researcher blindfolded to the NAA status of the patients. Results: We evaluated 37 consecutive patients (12 male, 25 female) with TLE. NAAs had already been detected for research purposes in the sera of 20 included patients; the antibodies were found against contactin associated protein-2 (CASPR2) in 7, N-methyl-D-aspartate receptor (NMDAR) in 6, voltage-gated potassium channel complex (VGKC-complex) in 3, glycine receptor in 3 and glutamic acid decarboxylase in one patient. Social phobia was found remarkably common in the seronegative group (p:0.015). Other psychiatric symptoms did not show any difference between the seropositive and seronegative groups. Conclusion: We could not demonstrate an alarming psychiatric profile related to NAAs in chronic TLE patients, in our small sized study. It was important to note that depression and psychosis are more frequent in patients with NAA, whereas seronega- tive patients displayed social phobia more frequently.

🔖

Cite This Article

SEZGİN, M., ÇIKRIKÇILI, U., KULAKSIZOĞLU, I. B., YAVUZ, E. N. V., BEBEK, N., TÜZÜN, E., BAYKAN, B. (2018). The psychiatric profiles of patients with temporal lobe epilepsy associated with neuronal auto-antibodies. Neurological sciences and neurophysiology (Online), Cilt: 35 - Sayı: 2, 84–90. https://ajindex.com/articles/290555

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010
  2. [CrossRef] Bien CG, Bauer J. Autoimmune Epilepsies. Neurotherapeutics 2014
  3. [CrossRef] Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004
  4. [CrossRef] Vincent A, Buckley C, Schott JM, et al. Potassium channel anti- body-associated encephalopathy: A potentially immunothera- py-responsive form of limbic encephalitis. Brain 2004
  5. [CrossRef] Bien CG, Elger CE. Limbic encephalitis: A cause of temporal lobe epilepsy with onset in adult life. Epilepsy Behav 2007
  6. [CrossRef] Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013
  7. [CrossRef] Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000
  8. [CrossRef] Ekizoglu E, Tuzun E, Woodhall M, et al. Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epi- lepsia 2014
  9. [CrossRef] Vanli-Yavuz EN, Erdag E, Tuzun E, et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry 2016
  10. [CrossRef] Ertekin BA, Kulaksizoğlu IB, Ertekin E, et al. A comparative study of obsessive-compulsive disorder and other psychiatric comorbidities in patients with temporal lobe epilepsy and idiopathic generalized epilepsy. Epilepsy Behav 2009
  11. [CrossRef] Sarkis RA, Nehme R, Chemali ZN. Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephali- tis. Epilepsy Behav 2014
  12. [CrossRef] Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Ballice-Gordon R. Clinical experience and laboratory investiga- tions in patients with anti-NMDAR encephalitis. Lancet Neurol 2012
  13. [CrossRef] Wong SH, Saunders MD, Larner AJ, Das K, Hart IK. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 2010
  14. [CrossRef] Engeler A, Sheehan DV, Lecruiber Y, Eds. MINI Internati